Cheaper AMD drug could lead to serious eye issues
A Queen's University study of two eye drugs used to treat wet Age-related Macular Degeneration (AMD) has determined the cheaper of the two could lead to eye inflammation, a potentially blinding adverse effect.
Jun 18, 2012
0
0